戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ts presenting with surgical complications or intercurrent abdominal pathology.
2 ression and episodes between visits 1 and 2 (intercurrent) and after visit 2 (subsequent).
3 f QIA progression (>=1.2%) had more frequent intercurrent ARD (incidence rate ratio [IRR] = 1.46 [95%
4 ue injury during chronic infection and acute intercurrent bacterial infections.
5 atrial fibrillation (AF) risk factors and/or intercurrent cardiovascular events could explain the rel
6  adjusted for changes in AF risk factors and intercurrent cardiovascular events, the HR for T2D was a
7  in PSC should be reserved for situations of intercurrent cholestasis and cholangitis, not for choles
8                                    Many have intercurrent comorbid illness.
9 isolated raised values associated with acute intercurrent complications causing major acute-phase res
10  agents for the management of concomitant or intercurrent conditions.
11 and none had recurrent angina or other major intercurrent coronary events.
12                           When patients with intercurrent death or MI were included, the primary outc
13                                Patients with intercurrent death or myocardial infarction (MI) were im
14               Of these, 222 were reported as intercurrent deaths (exemestane, 107; tamoxifen, 115).
15 cer-free survival (BCFS), with censorship of intercurrent deaths, was the primary survival end point
16 LC does not excessively increase the risk of intercurrent deaths.
17 s used to infer the serotype associated with intercurrent DENV infections.
18 ome studies report a high risk of death from intercurrent disease (DID) after postoperative radiother
19            The clinical course worsened with intercurrent disease or certain drugs in some patients;
20     A total of 25 patients (12.5%) died from intercurrent disease, 16 from confirmed noncancer causes
21 tive interventions performed on pseudocysts, intercurrent episodes of acute pancreatitis during the m
22 f at least 85% of the baseline value, and no intercurrent event (i.e., rescue therapy, treatment fail
23 CA was the cause of death (primary CA) or an intercurrent event (secondary CA).
24 reased the risk of stroke and death after an intercurrent event of ABC.
25 reased the risk of stroke and death after an intercurrent event of ABC.
26 o-creatinine ratio lower than 0.8 without an intercurrent event was more common with obinutuzumab tha
27 o-creatinine ratio lower than 0.8 without an intercurrent event.
28 teness of methods to handle missing data and intercurrent events (including death) were seldom discus
29 his information considered the occurrence of intercurrent events as irrelevant in the calculation of
30 ate mortality and stroke taking into account intercurrent events including kidney injury and the comp
31 expected to inform the transplant program of intercurrent events that may affect transplant candidacy
32                                              Intercurrent events were reported in 242 (95%) of 255 tr
33 andomly assigned participants, regardless of intercurrent events) was the primary estimand, with the
34 uses of additional drug treatments (known as intercurrent events), and the corresponding types of que
35    Challenges including the consideration of intercurrent events, the difficulty in maintaining adequ
36  lack of clarity on the approach to handling intercurrent events.
37 ile on intervention" strategy to account for intercurrent events.
38 clude age, total dose, duration, presence of intercurrent febrile illness, starvation, co-administrat
39 he possibility that the defective control of intercurrent gamma-herpesvirus infections in patients wi
40 lestasis of pregnancy without preexisting or intercurrent hepatic disorders.
41 didate AIDS vaccines, 23 were diagnosed with intercurrent human immunodeficiency virus type 1 (HIV-1)
42                                              Intercurrent IAV infections transiently increase the fre
43 ion and diagnosis of IBS and IBD and suggest intercurrent IGE may increase IBD risk in IBS patients.
44  Reasons for treatment interruption included intercurrent illness (31%), noncompliance (31%), and fin
45  due to early disease progression (n = 5) or intercurrent illness (n = 2).
46 cted participants, 1 was excluded because of intercurrent illness after the first visit and 1 withdre
47 anage oral anticoagulant use during an acute intercurrent illness and warrant further investigation i
48 suffer frequent hyperammonemic crises during intercurrent illness or other catabolic stresses.
49 cal progression, six distant metastases, one intercurrent illness), whereas 41 patients underwent sur
50  advice on how to increase medication during intercurrent illness, medical or dental procedures, and
51 t reasons for dropout were adverse events or intercurrent illness: 27 (34%) of dropouts, and insuffic
52 at careful monitoring and early treatment of intercurrent illnesses may be beneficial.
53 thy, together with timely treatment of acute intercurrent illnesses, may retard disease progression a
54 cores the need to prevent and promptly treat intercurrent illnesses.
55  factors were identified in only five cases: intercurrent infection (one); discontinuation of lithium
56 ot typical, and the latter two indicate that intercurrent infection may be present.
57 e problems, varying from a reaction to minor intercurrent infection that rapidly improves to the pres
58 le, at a low level, and can be influenced by intercurrent infection.
59 hird vaccine is at least partially driven by intercurrent infection.
60 tes as a cofactor with other insults such as intercurrent infections as a trigger of wheezing attacks
61 rial participants scored negative, while all intercurrent infections were detected within 1 to 3 mont
62 hrive, and recurrent metabolic acidosis with intercurrent infections.
63 ft rejection, immunosuppression, sepsis, and intercurrent infections; (4) in future transplantation t
64 f finding, change in size, and the status of intercurrent malignancy were recorded.
65 x months regarding hospitalizations or other intercurrent medical conditions.
66 condary causes leading to graft failure were intercurrent medical events in 36.3% of graft failures f
67 rIL-2 never initiated it because of refusal, intercurrent medical problems, or relapse, and 24 patien
68               The effects of comorbidity and intercurrent medications may alter the normal anesthetic
69 id not undergo surgical resection because of intercurrent metastatic disease.
70 ssociated with increased odds of one or more intercurrent (odds ratio [OR] = 1.29 [95% CI: 1.06, 1.56
71      Stability of anergy was associated with intercurrent opportunistic infections and AIDS-associate
72 ility in how weaning success is defined, how intercurrent OST-free periods are handled, and how death
73  bias favoring more severe cases and lack of intercurrent outbreaks (such as influenza) in the contro
74 ) separated by periods of low pollen counts (intercurrent periods).
75 early over 7 years and was not influenced by intercurrent phenoconversion.
76 ded by preexisting mental health conditions, intercurrent psychosocial stressors (including coronavir
77 raphic progression, with higher frequency of intercurrent severe events in those with faster progress
78 ge and was not associated with the number of intercurrent sex partners.
79      The full panel was convened twice, with intercurrent small group meetings, conference calls, and
80 neurodegeneration appeared to be prompted by intercurrent systemic infections with double-stranded DN
81 re to stresses such as fasting, exercise, or intercurrent viral illness.
82 e status is often transient, possibly due to intercurrent viral infection, highlighting potentially i